首页>
外国专利>
(Asu1.7) stabilization method null of aqueous solution injection medicine of karushitonin
(Asu1.7) stabilization method null of aqueous solution injection medicine of karushitonin
展开▼
机译:(Asu1.7)稳定剂karushitonin的水溶液注射药物无效
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE:To provide the subject aqueous solution injection containing a specified pH buffer and stabilized in a wider pH range than in the conventional one. CONSTITUTION:In an aqueous solution injection containing an [Asu1.7] calcitonin, e.g. elcatonin or [Asu1.7] human calcitonin as the active component, one or two or more kinds of compounds selected from a group of tris(hydroxymethyl) aminomethane, an amine compound of the formula (R1 to R3 are each H or CH2-CH2-OH, at least one of them is CH2-CH2-OH) and water-soluble salts thereof are contained as the pH buffers so as to stabilize the pH within a range of 6.5 to 8. This aqueous solution injection contains 0.01 to 100mug/ml calcitonin and 0.05 to 100 mM pH buffers.
展开▼
机译:目的:提供主题水溶液注射液,其中包含指定的pH缓冲液,并在比传统pH缓冲液宽的pH范围内稳定。组成:在含有[Asu <1.7>]降钙素的水溶液注射液中,例如降钙素或[Asu 1.7]人降钙素作为活性成分,选自三(羟甲基)氨基甲烷的一种或两种以上化合物,式(R1至R3的胺化合物)分别为H或CH2- CH2-OH,其中至少一种是CH2-CH2-OH),并包含其水溶性盐作为pH缓冲剂,以将pH稳定在6.5至8的范围内。该水溶液注射液中含有0.01至100 ug / ml降钙素和0.05至100 mM pH缓冲液。
展开▼